Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues

Ziemssen, Focke; Sobolewska, Bianka; Deissler, Heidrun; Deissler, Helmut

dc.contributor.author	Ziemssen, Focke
dc.contributor.author	Sobolewska, Bianka Weronika
dc.date.accessioned	2017-06-07T08:14:21Z
dc.date.available	2017-06-07T08:14:21Z
dc.date.issued	2016
dc.identifier.issn	1744-764X
dc.identifier.uri	http://hdl.handle.net/10900/76539
dc.language.iso	en	de_DE
dc.publisher	Taylor & Francis Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1517/14740338.2016.1121232	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issues	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160915142648_02024
utue.publikation.seiten	75-87	de_DE
utue.personen.roh	Ziemssen, Focke
utue.personen.roh	Sobolewska, Bianka
utue.personen.roh	Deissler, Heidrun
utue.personen.roh	Deissler, Helmut
dcterms.isPartOf.ZSTitelID	Expert Opinion on Drug Safety	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	15	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE